Clinical Trial Update: Lithium and Acetate for Canavan Disease [Phase 2]

View source ↗

Summary

Phase 2 trial investigating lithium acetate for Canavan disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Canavan Disease

Drugs mentioned

• Lithium acetate (lithium acetate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Canavan Disease, Infantile | Phase 2 | Status: WITHDRAWN